Tag Archives: SNY

Healthcare Sector Snapshot: Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS) – LLY, NVS, SNY

Posted on April 25, 2013 by Thomas Vedder

Investors responded negatively to the healthcare stocks on Wednesday. Key movement were observed in Edwards Lifesciences Corp (NYSE:EW) and Amgen, Inc (NASDAQ:AMGN) on percentage decliners side while BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) was prominent stock on percentage gainer side.

Eli Lilly …

Posted in Healthcare, Latest Headlines | Tagged Eli Lilly NYSE:LLY, LLY, Novartis, NVS, NYSE:NVS, NYSE:SNY, Sanofi, SNY | Comments Off

Johnson & Johnson (NYSE:JNJ) Profit Outshines Wall Street Estimates – JNJ, SNY, MYL, CNMD

Posted on April 17, 2013 by Thomas Vedder

Johnson & Johnson (NYSE:JNJ) announced on Tuesday that profit in fiscal Q1 plunged from previous year. However results surpassed forecasts on strong pharmaceutical sales.

Healthcare giant announced net earnings moved down to $3.5 billion or $1.22 a share from previous …

Posted in Healthcare, Latest Headlines | Tagged CNMD, CONMED, JNJ, Johnson, MYL, Mylan, NASDAQ:CNMD, NASDAQ:MYL, NYSE:JNJ, NYSE:SNY, Sanofi SA, SNY | Comments Off

Sanofi (NYSE:SNY) to Build New Plant in Vietnam to Meet Higher Demand; $75 Million Plan – SNY, BMY, GSK, MRK

Posted on April 1, 2013 by Thomas Vedder

Sanofi SA (ADR) (NYSE:SNY) announced on Friday that it will invest $75 million in a new facility in Vietnam to meet higher demand in the country for pharmaceuticals and consumer healthcare products.

French pharmaceutical company announced on Friday that the …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GlaxoSmithKline, GSK, Merck, MRK, NYSE:BMY, NYSE:GSK, NYSE:MRK, NYSE:SNY, Sanofi SA, SNY | Comments Off

Review of Hot Stocks with News: Accenture (NYSE:ACN), Sanofi (NYSE:SNY)

Posted on March 28, 2013 by Thomas Vedder

The Dublin, Ireland based Accenture Plc (NYSE:ACN) announced fiscal Q2 earnings moved up 71 percent as the company booked stronger revenue, while results were supported by special gains.

The consulting company reported that it projects revenue for the year to …

Posted in Latest Headlines | Tagged Accenture, CAN, NYSE:CAN, NYSE:SNY, Sanofi, SNY | Comments Off

Otelco Inc. (NASDAQ:OTT) Files for Bankruptcy, Sanofi SA (NYSE:SNY) and Transgene SA Inks Deal

Posted on March 25, 2013 by Thomas Vedder

Otelco Inc. (NASDAQ:OTT) willingly filed for Chapter 11 bankruptcy protection in an attempt to execute its formerly declared prepackaged reformation plan that would lower its total debt by almost $135 million.

The wireline telecommunication services provider, which concluded the third …

Posted in Latest Headlines | Tagged NASDAQ:OTT, NYSE:SNY, Otelco, OTT, Sanofi, SNY | Comments Off

Sanofi (NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Collaboration Turns Positive

Posted on March 4, 2013 by Thomas Vedder

Sanofi (NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported on Monday that outcomes from two studies of its therapy for atopic dermatitis were optimistic.

The drug firms reported that gathered data from two Phase 1b trials with dupilumab, an experimental antibody …

Posted in Latest Headlines | Tagged NASDAQ:REGN, NYSE:SNY, Regeneron Pharmaceuticals, REGN, Sanofi, SNY | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.